AC Immune (ACIU) Cash from Investing Activities Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 558.45% |
| Sep 30, 2025 | 1,170.53% |
| Jun 30, 2025 | 134.41% |
| Mar 31, 2025 | 112.48% |
| Dec 31, 2024 | -116.64% |
| Sep 30, 2024 | -145.08% |
| Jun 30, 2024 | -1,362.29% |
| Mar 31, 2024 | -158.33% |
| Dec 31, 2023 | 409.85% |
| Sep 30, 2023 | 200.78% |
| Jun 30, 2023 | -122.57% |
| Mar 31, 2023 | 8,013.88% |
| Dec 31, 2022 | 121.85% |
| Sep 30, 2022 | -883.56% |
| Jun 30, 2022 | 175.56% |
| Mar 31, 2022 | 33.08% |
| Dec 31, 2021 | -611.20% |
| Sep 30, 2021 | -103.36% |
| Jun 30, 2021 | -436.57% |
| Mar 31, 2021 | -298.67% |
| Dec 31, 2020 | 181.77% |
| Sep 30, 2020 | 250.98% |
| Jun 30, 2020 | 3,054.54% |
| Mar 31, 2020 | 99.57% |
| Dec 31, 2019 | 81.51% |
| Sep 30, 2019 | -7,412.38% |
| Jun 30, 2019 | 18.83% |
| Mar 31, 2019 | -4,046.49% |
| Dec 31, 2018 | -101.64% |
| Sep 30, 2018 | 99.99% |
| Jun 30, 2018 | 55.54% |
| Mar 31, 2018 | -91.59% |
| Dec 31, 2017 | 649,752.28% |
| Sep 30, 2017 | -607,350.18% |
| Jun 30, 2017 | -837.11% |
| Mar 31, 2017 | -201.92% |
| Dec 31, 2016 | -5,560.52% |